Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
March 06, 2026
January 28, 2026
November 13, 2025
August 07, 2025
June 11, 2025
June 06, 2025
April 29, 2025